NOX1 is upregulated in gallbladder cancer and associated with cisplatin-sensitivity.
Enforced NOX1 expression resulted in promotion of cisplatin-resistance in SGC-996.
Inhibition of NOX1 promotes the cisplatin-sensitivity of GBC-SD in vitro and in vivo.
NOX1-mediated chemoresistance is related with the ROS/HIF-1α/MDR1 pathway.